文献速递系统性红斑狼疮

淋巴细胞减少与SLE神经受累及器官损伤累积相关:多中心观察性研究

Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study.
PubMed 文献 · Semin Arthritis Rheum · 2020-03-04

该多中心观察性研究基于欧洲GIPT数据集286例SLE患者共1425次随访,分析血液学表现与临床变量及结局的关联。结果显示淋巴细胞减少(<1000/mm3)与血小板减少和神经受累相关,且为器官损伤累积的独立预测因素;严重淋巴细胞减少(<500/mm3)与感染风险增加独立相关,上述关联在瑞典1348例独立数据集中得到验证。

要点

  • 淋巴细胞减少(<1000/mm3)是SLE器官损伤累积的独立预测因素。
  • 严重淋巴细胞减少(<500/mm3)与感染风险增加独立相关。
  • 淋巴细胞减少与神经受累(ACR-8)及血小板减少相关。

核心结论

  • SLE患者的淋巴细胞减少与神经受累及器官损伤累积独立相关,可作为严重/进展性疾病的标志物。

研究设计与样本

  • 基于欧洲六个三级中心SLE患者的GIPT数据集,纳入286例有血液学表现的患者,每6个月随访至少2年,共1425次随访。
  • 结果与瑞典1348例SLE患者的横断面数据集进行验证比较。

主要发现

  • 血小板减少(回归系数1.86[95%CI 1.1-3.13])和神经受累(ACR-8)(2.1[95%CI 1.10-3.89])与淋巴细胞减少(<1000/mm3)相关。
  • 淋巴细胞减少(<1000/mm3)是器官损伤累积的独立预测因素(1.68[95%CI 1.2-2.62])。
  • 严重淋巴细胞减少(<500/mm3)与感染风险增加独立相关(HR 2.56[95%CI 1.23-5.31])。
  • 严重血小板减少(<20 K/mm3)与出血风险增加独立相关(HR 4.38[95%CI 2.10-11.1])。

临床怎么用

  • 对SLE患者应关注淋巴细胞计数,淋巴细胞减少(<1000/mm3)提示神经受累及器官损伤累积风险较高。
  • 严重淋巴细胞减少(<500/mm3)提示感染风险增加,需加强监测与预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Detailed analysis of hematological manifestations (HM) in systemic lupus erythematosus (SLE) are limited and their clinical impact on disease remain obscure. Here, we aimed to decipher factors associated with different hematological abnormalities in SLE patients and to assess their impact on disease related outcomes. METHODS: A dataset (GIPT) originating from SLE patients of six European tertiary centers was assessed. Six-monthly visits of each patient for at least 2 years were registered. The association between hematologic manifestations (HM; per ACR-1997criteria) and clinical/serologic variables, as well as the impact of HM on disease related outcomes (damage, infection and hemorrhage) were explored. Scores on the Systemic Lupus Erythematosus Disease Activity Index 2000(SLEDAI2K), the Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) and events for any infection and hemorrhage were recorded. Results were compared with a cross-sectional, well-characterized SLE dataset from Sweden. Descriptive statistics, the generalized estimating equations (GEE), general linear models (GLM), Cox regression models were applied. RESULTS: We monitored 1425 longitudinal visits in 286 SLE patients with HM (GIPT dataset: 88% female, 95% Caucasian, 68% dsDNA positive). Thrombocytopenia (regression coefficient [95% confidence interval] 1.86[1.1-3.13]) and neurologic involvement (ACR-8) (2.1[1.10-3.89]) were associated with lymphopenia (<1000/mm3); the latter was an independent predictor of organ damage accrual (1.68[1.2-2.62]). These associations were confirmed in an independent dataset of 1348 SLE patients (86% female, 93% Caucasian, 61% dsDNA positive) in Sweden.Severe lymphopenia (<500/mm3) and severe thrombocytopenia (<20 K/mm3) were associated with increased risk for infection (hazard ratio [95% confidence interval] 2.56[1.23-5.31]) and hemorrhage (4.38[2.10-11.1]), respectively, independent of the effect of other predictors. CONCLUSION: Lymphopenia in SLE is independently associated with neurologic involvement and organ damage accrual, and thus, may be considered as a marker of severe/progressive disease.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Yavuz S, Cansu DU, Nikolopoulos D, et al. Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study. Semin Arthritis Rheum. 2020. PMID: 32229040. doi:10.1016/j.semarthrit.2020.02.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。